OTCMKTS:ZYXI - Zynex Stock Price, Price Target & More

$3.20 -0.05 (-1.54 %)

(As of 04/26/2018 04:00 PM ET)

Previous Close$3.25

Today's Range$3.17 - $3.25

52-Week Range$0.27 - $5.50

Volume11,489 shs

Average Volume43,405 shs

Market Capitalization$106.64 million

P/E Ratio14.55

Dividend YieldN/A

Beta0.87

About Zynex (OTCMKTS:ZYXI)

Zynex, Inc., a medical technology company, designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. Its products include NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; and InWave, an electrical stimulation product for the treatment of female urinary incontinence. The company also distributes private labeled products, such as electrodes for the delivery of electrical current to the body; batteries for use in electrotherapy products; Comfortrac for cervical traction; JetStream for hot/cold therapy; and LSO Back Braces for lumbar support. In addition, it develops non-invasive blood volume monitors for use in hospitals and surgery centers. The company offers its products for pain management and control; and stroke and spinal cord injury rehabilitation. It sells its products through direct and independent sales representatives primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Receive ZYXI News and Ratings via Email

Sign-up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment

Sub-IndustryN/A

SectorMedical

SymbolOTCMKTS:ZYXI

CUSIPN/A

Webwww.zynexmed.com

Phone303-703-4906

Debt

Debt-to-Equity RatioN/A

Current Ratio2.09%

Quick Ratio1.98%

Price-To-Earnings

Trailing P/E Ratio14.55

Forward P/E Ratio10.67

P/E GrowthN/A

Sales & Book Value

Annual Sales$23.43 million

Price / Sales4.52

Cash Flow$0.2469 per share

Price / Cash12.96

Book Value$0.15 per share

Price / Book21.33

Profitability

EPS (Most Recent Fiscal Year)$0.22

Net Income$7.36 million

Net Margins31.97%

Return on Equity1,826.83%

Return on Assets132.21%

Miscellaneous

Employees109

Outstanding Shares33,120,000

Zynex (OTCMKTS:ZYXI) Frequently Asked Questions

What is Zynex's stock symbol?

Zynex trades on the OTCMKTS under the ticker symbol "ZYXI."

How were Zynex's earnings last quarter?

Zynex Inc. (OTCMKTS:ZYXI) posted its quarterly earnings results on Wednesday, February, 28th. The company reported $0.10 EPS for the quarter, beating the consensus estimate of $0.09 by $0.01. The business earned $8.13 million during the quarter, compared to analysts' expectations of $7.20 million. Zynex had a return on equity of 1,826.83% and a net margin of 31.97%. View Zynex's Earnings History.

Who are some of Zynex's key competitors?

Some companies that are related to Zynex include Rockwell Medical (RMTI), Vision Sciences (CGNT), Fonar (FONR), Helius Medical Technologies (HSDT), Second Sight Medical (EYES), Biolife Solutions (BLFS), Viveve Medical (VIVE), Edap Tms (EDAP), IRIDEX (IRIX), BioSig Technologies (BSGM), Semler Scientific (SMLR), Stereotaxis (STXS), Soleno Therapeutics (SLNO), Digirad (DRAD) and Nexeon MedSystems (NXNN).

Who are Zynex's key executives?

Zynex's management team includes the folowing people:

Mr. Thomas Sandgaard, Founder, Pres, CEO & Chairman (Age 59)
Mr. Daniel J. Moorhead, Chief Financial Officer (Age 46)
Mr. David B. Mogill, VP of Operations
Mr. Robert Bird, VP of Marketing
Mr. Steve Siefring, Director of Bus. Devel.

Has Zynex been receiving favorable news coverage?

News headlines about ZYXI stock have been trending somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Zynex earned a coverage optimism score of 0.04 on Accern's scale. They also gave news headlines about the company an impact score of 47.23 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

How do I buy shares of Zynex?

Shares of ZYXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Zynex's stock price today?

One share of ZYXI stock can currently be purchased for approximately $3.20.

How big of a company is Zynex?

Zynex has a market capitalization of $106.64 million and generates $23.43 million in revenue each year. The company earns $7.36 million in net income (profit) each year or $0.22 on an earnings per share basis. Zynex employs 109 workers across the globe.

How can I contact Zynex?

Zynex's mailing address is 9555 MAROON CIRCLE, ENGLEWOOD CO, 80112. The company can be reached via phone at 303-703-4906 or via email at [email protected]

MarketBeat Community Rating for Zynex (ZYXI)

Community Ranking:		2.5 out of 5 ( )
Outperform Votes:		37 (Vote Outperform)
Underperform Votes:		37 (Vote Underperform)
Total Votes:		74

MarketBeat's community ratings are surveys of what our community members think about Zynex and other stocks. Vote "Outperform" if you believe ZYXI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZYXI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Zynex (OTCMKTS:ZYXI) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

1 Wall Street analysts have issued ratings and price targets for Zynex in the last 12 months. There are currently 1 hold rating for the stock, resulting in a consensus rating of "Hold."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Hold	Hold	Hold	Hold
Consensus Rating Score:	2.00	2.00	2.00	2.00
Ratings Breakdown:	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	N/A	N/A
Price Target Upside:	N/A	N/A	N/A	N/A

Zynex (OTCMKTS:ZYXI) Consensus Price Target History

Price Target History for Zynex (OTCMKTS:ZYXI)

Zynex (OTCMKTS:ZYXI) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Details
8/21/2017	Taglich Brothers	Reiterated Rating	Speculative Buy

(Data available from 4/26/2016 forward)

Zynex (OTCMKTS:ZYXI) Earnings History and Estimates Chart

Earnings by Quarter for Zynex (OTCMKTS:ZYXI)

Zynex (OTCMKTS:ZYXI) Earnings Estimates

2018 EPS Consensus Estimate: $0.22
2019 EPS Consensus Estimate: $0.35

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.08	$0.08	$0.08
Q3 2018	1	$0.06	$0.06	$0.06
Q4 2018	1	$0.08	$0.08	$0.08
Q1 2019	1	$0.04	$0.04	$0.04
Q2 2019	1	$0.10	$0.10	$0.10
Q3 2019	1	$0.11	$0.11	$0.11
Q4 2019	1	$0.10	$0.10	$0.10

Zynex (OTCMKTS ZYXI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
2/28/2018	Q4 2017	$0.09	$0.10	$7.20 million	$8.13 million	View	N/A
11/13/2017	Q3 2017	$0.06	$0.07	$5.52 million	$6.82 million	View	N/A
8/14/2017	Q2 2017		$0.05		$5.04 million	View	N/A
5/15/2017	Q1 2017		$0.01		$3.44 million	View	N/A
11/10/2016	Q3 2016		$0.02		$3.63 million	View	N/A
8/22/2016	Q2 2016		($0.01)		$3.29 million	View	N/A
5/19/2016	Q1 2016		($0.01)		$3.48 million	View	N/A
3/31/2016	Q4 2015		($0.04)		$2.72 million	View	N/A
11/17/2015	Q3 2015		($0.01)		$2.67 million	View	N/A
8/13/2015	Q2 2015		($0.02)		$3.07 million	View	N/A
5/12/2015	Q1 2015		($0.03)		$3.18 million	View	N/A
4/2/2015		($0.07)	($0.05)		$2.20 million	View	N/A
11/7/2014	Q3 14	($0.01)	$0.01	$3.93 million	$4.40 million	View	N/A
9/25/2014		($0.03)	($0.18)			View	N/A
9/25/2014	Q2 14		$0.18	$3.34 million	$1.35 million	View	N/A
5/13/2014		($0.04)	($0.05)			View	N/A
5/13/2014	Q1 14	($0.03)	($0.05)	$3.20 million	$3.17 million	View	N/A
3/27/2014		($0.03)	($0.14)	$5.01 million	$3.35 million	View	N/A
11/7/2013		($0.04)	($0.02)			View	N/A
11/7/2013	Q3 13	($0.04)	($0.02)	$5.30 million	$5.19 million	View	N/A
8/8/2013	Q2 2013	$0.01	($0.06)	$8.78 million	$5.47 million	View	N/A
5/8/2013	Q1 2013	$0.01	($0.01)	$9.85 million	$7.67 million	View	N/A
3/14/2013	Q4 2012	$0.02	$0.01			View	N/A
11/7/2012	Q3 2012	$0.02	$0.01			View	N/A
8/7/2012	Q2 2012	$0.02	$0.02			View	N/A
5/8/2012	Q1 2012		$0.01			View	N/A
3/15/2012	Q4 2011	$0.03	$0.02			View	N/A
11/3/2011	Q3 2011	$0.02	$0.02			View	N/A
8/3/2011	Q2 2011	$0.02	$0.02			View	N/A
11/8/2010	Q3 2010		$0.01			View	N/A
3/25/2010	Q4 2009		$0.01			View	N/A
11/17/2009	Q3 2009		$0.02			View	N/A
8/14/2009	Q2 2009		$0.02			View	N/A
5/15/2009	Q1 2009		$0.03			View	N/A

(Earnings results data provided by Zacks Investment Research)

Zynex (OTCMKTS:ZYXI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Zynex (OTCMKTS ZYXI) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.04%

Insider Trading History for Zynex (OTCMKTS:ZYXI)

Zynex (OTCMKTS ZYXI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details

(Data available from 1/1/2013 forward)

Zynex (OTCMKTS ZYXI) News Headlines

Source:

Date	Headline
	Financial Analysis: Zynex (ZYXI) & Its Competitors www.americanbankingnews.com - April 23 at 11:14 PM
	Reviewing Zynex (ZYXI) & Its Competitors www.americanbankingnews.com - April 21 at 5:14 PM
	Head-To-Head Review: Zynex (ZYXI) vs. Its Peers www.americanbankingnews.com - April 10 at 5:18 AM
	Zynex (ZYXI) & Its Rivals Critical Survey www.americanbankingnews.com - April 9 at 9:22 PM
	Zynex (ZYXI) Upgraded by Zacks Investment Research to Buy www.americanbankingnews.com - March 15 at 12:16 PM
	Taglich Brothers Equities Analysts Increase Earnings Estimates for Zynex Inc. (ZYXI) www.americanbankingnews.com - March 12 at 4:21 AM
	Seethru Equity Comments on Zynex Inc.'s FY2018 Earnings (ZYXI) www.americanbankingnews.com - March 12 at 4:21 AM
	Consilium Global Research Issues Quarterly Update on Zynex, Inc (OTCQB: ZYXI) www.baystreet.ca - March 8 at 11:09 AM
	Head-To-Head Analysis: AxoGen (AXGN) & Zynex (ZYXI) www.americanbankingnews.com - March 1 at 7:16 PM
	AxoGen (AXGN) vs. Zynex (ZYXI) Critical Contrast www.americanbankingnews.com - March 1 at 3:02 PM
	Head-To-Head Contrast: Zynex (ZYXI) & Integer (ITGR) www.americanbankingnews.com - February 28 at 11:50 AM
	Zynex Announces 2017 Fourth Quarter Earnings finance.yahoo.com - February 28 at 10:27 AM
	Head-To-Head Review: Zynex (ZYXI) & AxoGen (AXGN) www.americanbankingnews.com - February 27 at 11:16 PM
	Head-To-Head Contrast: AxoGen (AXGN) versus Zynex (ZYXI) www.americanbankingnews.com - February 27 at 10:10 AM
	Critical Review: Zynex (ZYXI) versus Integer (ITGR) www.americanbankingnews.com - February 23 at 3:16 AM
	Zynex Schedules 2017 Fourth Quarter and Full Year Earnings Release and Webcast finance.yahoo.com - February 22 at 10:13 AM
	AxoGen (AXGN) & Zynex (ZYXI) Financial Survey www.americanbankingnews.com - February 17 at 1:18 PM
	Financial Survey: Zynex (ZYXI) versus Medtronic (MDT) www.americanbankingnews.com - February 10 at 9:02 PM
	Financial Comparison: Medtronic (MDT) vs. Zynex (ZYXI) www.americanbankingnews.com - February 9 at 12:53 PM
	Zynex (ZYXI) & AxoGen (AXGN) Head to Head Comparison www.americanbankingnews.com - February 7 at 3:08 AM
	Contrasting Zynex (ZYXI) & Arch Therapeutics (ARTH) www.americanbankingnews.com - February 5 at 11:14 PM
	Zynex (ZYXI) Upgraded by ValuEngine to "Buy" www.americanbankingnews.com - February 4 at 6:22 AM
	Zynex (ZYXI) Downgraded to Hold at Zacks Investment Research www.americanbankingnews.com - February 3 at 4:54 PM
	Zynex introduces the NeuroMove™ Device to its expanding sales force finance.yahoo.com - February 1 at 5:06 PM
	ValuEngine Downgrades Zynex (ZYXI) to Hold www.americanbankingnews.com - January 25 at 11:16 PM
	Zynex Inc. Expected to Earn FY2017 Earnings of $0.21 Per Share (ZYXI) www.americanbankingnews.com - January 18 at 6:08 AM
	SeeThruEquity Issues Update on Zynex, Inc. finance.yahoo.com - January 16 at 5:47 PM
	Zynex Appoints Two New Independent Board of Directors finance.yahoo.com - January 12 at 5:36 PM
	Zynex, Inc. :ZYXI-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018 finance.yahoo.com - January 1 at 5:43 PM
	A Growing Medical Device Player Aiming to Rule the $6.3 Billion Pain Market; An Exclusive Interview with Zynex CEO Thomas Sandgaard finance.yahoo.com - December 20 at 5:45 PM
	Consilium Global Research Initiates Coverage of Zynex, Inc (OTCQB: ZYXI) finance.yahoo.com - December 13 at 9:12 AM
	Zynex Announces Share Buyback Program finance.yahoo.com - December 6 at 5:51 PM
	Zynex Inc. to Post FY2018 Earnings of $0.28 Per Share, Seethru Equity Forecasts (ZYXI) www.americanbankingnews.com - December 1 at 8:52 PM
	FY2017 EPS Estimates for Zynex Inc. (ZYXI) Raised by Analyst www.americanbankingnews.com - November 30 at 6:00 AM
	Zynex to Present at the 10th Annual LD Micro Main Event finance.yahoo.com - November 29 at 8:55 AM
	Zynex Announces Webinar to Address the US Opioid Epidemic finance.yahoo.com - November 28 at 11:26 AM
	SeeThruEquity Issues Update on Zynex, Inc., Raising Price Target to $5.00 finance.yahoo.com - November 28 at 11:26 AM
	Zynex Inc. (ZYXI) Upgraded by Zacks Investment Research to Buy www.americanbankingnews.com - November 23 at 10:34 AM
	Taglich Brothers Comments on Zynex Inc.'s Q4 2017 Earnings (ZYXI) www.americanbankingnews.com - November 23 at 9:20 AM
	Taglich Brothers Analysts Increase Earnings Estimates for Zynex Inc. (ZYXI) www.americanbankingnews.com - November 22 at 5:52 AM
	Zynex Inc. (ZYXI) Issues Earnings Results www.americanbankingnews.com - November 14 at 9:35 AM
	Zynex Inc to Host Earnings Call finance.yahoo.com - November 13 at 10:23 AM
	Zynex Announces 2017 Third Quarter Earnings finance.yahoo.com - November 13 at 10:23 AM
	Zynex Schedules 2017 Third Quarter Earnings Release and Webcast finance.yahoo.com - November 7 at 4:23 PM
	Zynex Presentation Now Available for On-Demand Viewing finance.yahoo.com - November 6 at 9:55 AM
	Zynex Inc. (ZYXI) Lowered to "Hold" at ValuEngine www.americanbankingnews.com - October 31 at 10:34 PM
	Zynex to Webcast, Live, at VirtualInvestorConferences.com November 2nd finance.yahoo.com - October 30 at 8:53 AM
	Zynex Growth Leads to a New Corporate Headquarters finance.yahoo.com - October 29 at 5:41 AM
	SeeThruEquity Initiates Coverage on Zynex, Inc.with a Price Target of $4.00 finance.yahoo.com - October 23 at 9:25 AM
	Zynex Provides an Overview of the Company's Medical Devices, NexWave and NeuroMove, in New SNNLive Video Interview on StockNewsNow.com finance.yahoo.com - October 18 at 11:04 AM

Zynex (OTCMKTS:ZYXI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Financials are not available for this stock.

Zynex (OTCMKTS ZYXI) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff